Active surveillance (AS) is the standard of care for low-risk prostate cancer management worldwide. But how long do patients benefit from AS before they need further treatment
Prof. Maude Laberge said the lines outside testing centres might come as a surprise for those who thought vaccination would provide a way out of the pandemic.
Patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who also carry the G12C mutation in the KRAS gene now have the option of newly approved sotorasib.